Journal of Heart and Lung Transplantation

Article	Citations
Expecting the unexpected, and prioritizing the predictable	420
A growing trend: CFTR modulators for cystic fibrosis lung transplant recipients	297
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	198
Information for Readers	159
The gift of organ donation as a last wish	139
Piwi-interacting RNAs (piRNAs), potential new liquid biopsy in the immune surveillance of heart transplant recipients	113
Impact of anticoagulation intensity on blood transfusion for venoarterial extracorporeal membrane oxygenation during lung transplantation	106
Novel therapeutic agents for cardiometabolic risk mitigation in heart transplant recipients	82
Right ventricular reserve in cardiopulmonary disease: A simultaneous hemodynamic and three-dimensional echocardiographic study	80
Editorial Board	61
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease	60
Balloon pulmonary angioplasty: Not quite the fountain of youth in chronic thromboembolic pulmonary hypertension	54
Donor to recipient age matching in lung transplantation: A European experience	54
Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH	52
Incompleteness of health-related quality of life assessments before left ventricular assist device implant: A novel quality metric	51
Strategies for bridge to heart transplantation: Percutaneous mitral valve repair and LVAD	49
Untangling severe pulmonary hypertension in chronic obstructive pulmonary disease	47
Residual mitral regurgitation in patients with left ventricular assist device support – An INTERMACS analysis	47
Long term employment following heart transplantation in the United States	47
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	47
Living-donor lobar lung transplantation	46
Editorial Board	45
Table of Contents	41
Editorial Board	40
Editorial Board	39

Editorial Board	38
Implications of and potential solutions for the weekend effect in heart transplantation	38
Pregnancy in PAH: Reality is changing	37
Lung transplant waitlist outcomes among ABO blood groups vary based on disease severity	37
Information for Readers	37
Post-transplant diabetes mellitus following heart transplantation	37
Table of Contents	36
Disseminated Pulmonary Kaposi Sarcoma After Lung Transplantation: The Increased Risk Donor	36
Response to JHLT-D-21-00302 "Failing Fontan – heart or heart-liver transplant: The jury is (still) out?"	36
Not just for the birds: The emerging role of B cells in transplant immunology	35
Table of Contents	34
Editorial Board	33
Table of Contents	33
The lung microbiome in lung transplantation	33
Editorial Board	32
(997) Routine Donor Specific Antibody Monitoring in Heart Transplant Recipients - Is There a Role?	32
Right Heart Reverse Remodeling Correlates with NT-proBNP Outcomes Among Pulmonary Arterial Hypertension Patients on Combination Therapy	30
(701) Use of Tixagevimab and Cilgavimab (Evusheld) and Subsequent Outcomes of SARS-CoV-2 Infections in Lung Transplant Recipients	30
Table of Contents	30
Right heart failure after left ventricular assist device implantation – from prediction to action	29
Table of Contents	29
Information for Readers	28
Cardiac Donation After Circulatory Death in Adult Congenital Heart Disease: Early Experiences and Outcomes	27
(506) Characterization of Donor-Derived Cell-Free DNA Results in Cardiac Donation after Brain Death vs. Donation after Cardiac Death	27
Patient-centered real-world registry analysis of cfLVAD recipients: From survival to freedom from hospitalization and beyond	27
Table of Contents	26
Editorial Board	26
CD8+ T cell-mediated rejection of allogenic human-induced pluripotent stem cell-derived cardiomyocyte sheets in human PBMC-transferred NOG MHC double knockout mice	26
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	26
Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension	25
Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation	25
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	25
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	25
Impact of the coronavirus disease 2019 pandemic on drug overdoses in the United States and the effect on cardiac transplant volume and survival	25
Information for Readers	25
Outcomes following lung transplantation for American Indians/Alaska Natives in the United States	25
Table of Contents	25
Relationship between blood and tissue-based rejection-related transcripts in heart transplantation	24
Information for Readers	24
A multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis	23
Information for Readers	23
Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT)	23
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients	23
Extra-cardiac management of cardiogenic shock in the intensive care unit	23
Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership	22
(1222) Identifying Imaging Biomarkers Before the Onset of Chronic Lung Allograft Dysfunction	22
Table of Contents	21
Preservation of Bronchial Artery Circulation on Ex-Vivo Lung Perfusion	21
Editorial Board	21
An Unusual Presentation of Pulmonary Cryptococcosis in a Bilateral Lung Transplant Patient	21

Adults with “Fontan Associated Liver Failure”- Is Combined Heart Liver Transplantation Always Necessary?	21
Adult congenital heart disease patients undergoing mechanical circulatory support: Not all patients are the same	21
Donor transmitted and de novo coronary plaque through the OCT magnifying lens	21
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	21
Does Timing Matter: Assessing the Impact of Nighttime Lung Transplantation on Patient Outcomes	21
First North American Experience with The Berlin Heart Active Driver	21
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	20
Impact of Diaphragmatic Plication on Lung Function Parameters and Long-Term Outcomes After Lung Transplantation	20
Predicted Total Lung Capacity is a Reliable Size-Matching Parameter in Lung Transplantation for Pulmonary Fibrosis	20
Peri-Operative Strategy Using Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension	20
Impact of Cumulative Vasopressor and Inotrope Medications on Outcomes in Cardiogenic Shock: A Cardiogenic Shock Working Group Report	20
Trends in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients	20
Comparative Analysis of Fontan Transplant Outcomes	20
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	19
Right Ventricular Contractile Reserve in Cardiopulmonary Diseases: A Simultaneous Hemodynamic and 3D Echocardiographic Study	19
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	19
A Comparative Study Between Single vs Standard Two Doses of Basiliximab in Lung Transplantation	19
Impact of the New 2018 US Donor Heart Allocation System on the Long-Term Outcomes in Patients with Hypertrophic Cardiomyopathy	19
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	19
WITHDRAWN	19
Pulmonary Vein Stenosis in Pediatric Heart Transplant Recipients: A Single-Center Case Series	19
Dapagliflozin for Graft Dysfunction After Pediatric Heart Transplant	18
Asymptomatic Viral Carriage in Lung Transplant Recipients and Donors on Day of Transplant	18
Kaposi Sarcoma Due to Possible Donor-Derived Human Herpesvirus-8 Infection in a Cardiac Transplant Recipient	18
Endothelin-1 Levels in Exercise-Induced Pulmonary Hypertension	18
Evaluation of the Impact of Pharmacist Transitions of Care Interventions in Hospitalized Heart Failure Patients	18
Acute Hemodynamic and Echocardiographic Consequences of Surgically-Implanted Axial Flow Pumps in Patients with Cardiogenic Shock	18
Association of ECMO Flow Index and Survival in Adults with Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation with Concomitant Left Ventricular Mechanical Unloading Device: A	18
Early Conversion from Tacrolimus- to Everolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients for Renal Insufficiency	18
Failure to Rescue in Heart Lung Transplantation: Progress Over 30 Years	18
Impact of Occurrence of Cardiac Arrest on Post-transplant Survival in Brain-Dead Donors: A French National Cohort Study	17
Fully Automated versus Core Laboratory Analysis of Tricuspid Regurgitation Maximal Velocity in Patients with Pulmonary Hypertension	17
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	17
Combined Heart-Liver Transplantation: Indications, Outcomes, and Risk Factors	17
Donor “Left Ventricular Hypertrophy” is Often Transient and/or Spurious	17
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	17
Pirfenidone and Nintedanib Monotherapy Reduce Cardiac Allograft Vasculopathy in a Murine Transplantation Model	17
The ABCs of DSAs: Incidence, Class, Gene and Strength of Donor Specific Antibody Development in the First Year After Heart Transplant	16
Outcomes of Concomitant Tricuspid Valve Repair with Contemporary Ventricular Assist Device Implantoutcomes Outcomes of Concomitant Tricuspid Valve Repair with Contemporary Left Ventricular Assist Devi	16
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	16
Impact of Hepatitis C Viremic Lung Donors on Waitlist Time and Outcomes in High-Risk Recipients	16
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	16
Myocardial Bridge in Donor Heart is Not Associated with Worse Survival After Orthotopic Heart Transplant	16
Any Switch Way: Cure of Donor-Derived HCV Infection after Changing DAA Therapy Due to Drug Interactions	16
Impact of Perioperative Gabapentinoid Use on Lung Transplant Outcomes	16
The Impact of Pre-Transplant Mental Toughness on Short-Term Outcomes in Lung Allograft Recipients	16
Using Machine Learning to Assess the Predictive Power of Donor Characteristics in Pediatric Heart Transplant Outcomes	16
WITHDRAWN	16
Transcriptomic Signatures of Human Donor Hearts Preserved Using a Hypothermic Perfusion System	16
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	16
When LVAD Support is Just Too Much - A Case of Accelerated Myocardial Recovery with LVAD	15
12-Hour Hypothermic Heart Preservation in a Pig Model	15
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	15
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	15
Indirect Recognition HLA Score as a Predictor of CLAD In Lung Transplant	15
Impact of HF Etiology on the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis	15
Concomitant Heart and Lung Surgery During Lung Transplantation	15
Randomized Controlled Trial Comparing Immediate versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients; The Revolution Trial	15
Shifting Strategies: Heart Transplant as a Bridge to Chemotherapy in Cardiac Al Amyloidosis	15
Incidence and Risk Factors for Rejection After Conversion to Sirolimus-Based Immunosuppression in Orthotopic Heart Transplant Recipients	14
Clinical Features to Predict Weaning from Ventricular Assist Device in Pediatric Patients with Myocarditis	14
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	14
Explantation of Durable Ventricular Assist Device for Myocardial Functional Recovery in Children: A Report from The Action Registry	14
Transfusion-Induced HLA Antibodies Are Transient in Heart Transplant Patients	14
Prevalence and Outcomes of Reduced Intensity Anticoagulation in Patients Supported with Left Ventricular Assist Devices	14
Clinical Outcomes with Intra-Aortic Balloon Pump in Cardiogenic Shock Due to Acute Myocardial Infarction or Heart Failure: A Report from the Cardiogenic Shock Working Group	14
Does It Make a Difference? Generic versus Brand-Name Immunosuppression Following Heart Transplant: An Analysis of the UNOS Database	14
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	14
Socioeconomic Deprivation Predicts Worse Post-Transplant Survival in US Pediatric Heart Transplantation	14
A Single-Center Experience with Delayed Heparin Initiation Following Heartmate3 Implantation	14
Older Donor Hearts for Heart Transplantation	14
Nirmatrelvir-Ritonavir Drug Interactions Lead to Multi-Organ Dysfunction in a Lung Transplant Recipient	14
COVID-19 Seropositive Donors Yield Comparable Post-Lung Transplant Outcomes	13
Cryoablation for Ventricular Arrhythmia During Left Ventricular Assist Device Implantation is Safe and Feasible: A Retrospective Cohort Study	13
Subaortic Pannus Causing Complete Outlet Obstruction After Bioprosthetic Aortic Valve Replacement in Left Ventricular Assist Device Patient	13
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	13
Lung Transplantation in a Recipient with True Tracheal Bronchus	13
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	13
Impella 5.5 for Frailty and SCAI D-E Shock: Impact on Post-OHT Oucomes	13
The Landscape of Referral for Lung Transplantation in Pulmonary Arterial Hypertension: A Report From the Phar	13

Measuring Donor Lung Temperature in Clinical Lung Transplantation: Controlled Hypothermic Storage versus Static Ice Storage	13
Engraftment of Alveolar Macrophages from Human LT Recipients into Immunodeficient Mice as a Tool to Study Mechanisms of Lung Allograft Inflammation	13
WITHDRAWN	13
Improved 2-Year Heart Transplant Survival with Moderate Hypothermic Donor Heart Preservation in the Guardian Heart Registry	13
Combined Heart and Lung Transplantation Across Preformed Donor-Specific Antibodies Using a Peritransplant Desensitization Protocol	13
Adaptive Growth of Heart Valves in Pediatric Orthotopic Heart Transplants	13
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	13
Seeing is Believing: Mouse Orthotopic Vascularized Right Lung Transplantation	13
HOPE For a Bright Future	13
A Newly Produced Polymerized Bovine Hemoglobin and Hemoglobin-Based Heart Preservation Solution Prolonged Preservation Duration of Donor Heart in Cold Static Storage and Reduced Myocardial Injury Afte	13
The Ability of an Electronic Nose to Distinguish Between Infections in Lung Transplant Recipients	13
The Respiratory Physiotherapy, a New Tool to Increase the Lung Donors Pool	13
Paraesophageal Hernia Repair in a Lung Transplant Recipient: Is It Safe?	13
Inconceivable: Outcomes of Contraception in LVAD-Supported Women of Childbearing Age	13
Allosensitized Cardiac Transplant Recipients Treated with CD38-Antibody Daratumumab Show Histomorphologic Signs of PAMR in Biopsies without Clinical Signs of Rejection	13
Age and its Relationship to Six-Minute Walk Distance, Functional Class, and Right Ventricular Function in Pulmonary Arterial Hypertension	13
Heart Rate Variability (HRV) as a Marker of Treatment Response in PAH	13
A Single Institutional Experience of Heart Transplantation in Children with Functional Single Ventricle	12
A Comprehensive Risk Score to Predict One Year Mortality After Heart-Lung Transplantation	12
Extensive Metastatic Calcification After Heart Transplant	12
Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)	12
Geographic Variation in Rank Priority Waiting Time in the United States Heart Allocation System	12
Myocardial Recovery in Contemporary CF-LVADs and Association with Outcomes - A VAD Wean Registry Analysis	12
The Minnesota Pectoralis Risk Score Predicts Right Ventricular Failure After LVAD Implantation	12
Early Onset Malignancy in the First-Year After Heart Transplantation	12
Transpulmonary Pressures Evaluation for Optimizing Ventilation in Bilateral Lung Transplants Recipients	12
Value of PIRCHE-II Score Determination in Risk Stratification of Rejection and Long-Term Graft Survival in Heart Transplantation	12
Ex Vivo Myocardial Slices Unveil Reversibility in Chemotherapy-Induced Cardiotoxicity	12
Predicting Donor Supply and Waitlist Compatibility Under the Composite Allocation Score	12
A Center’s 12 Year Experience in Heart Transplant with Patients Who Decline Blood Transfusion	12
Heart Transplantation for Cardiac Amyloidosis: The Road Less Traveled	12
Genotype Analysis of LVOT Gradient Measurements in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy?	12
Rejection Unmasks a Surprise	12
The Role of CD31 in Acute Cellular Rejection Following Clinical Lung Transplantation	12
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	12
Cardiac Recovery and Improved Outcomes During Left Ventricular Assist Device Support: The First Heart-Mate 3 in Argentina	12
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	12
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	12
Long-Term Maintenance of Pulmonary Function in the Contralateral Unaffected Lung with Chronic Lung Allograft Dysfunction After Bilateral Living-Donor Lobar Lung Transplantation	12
Acute Tacrolimus Toxicity Due to Paxlovid Successfully Managed with Phenytoin After Lung Transplantation	12
Should Living Alone be an Absolute Contraindication to HeartMate 3 Implantation: A Single Center Experience	12
Amiodarone Use in Post-Orthotopic Transplant Patients - A Pilot Study	11
Meticulous Donor Evaluation Makes Transplantation of Hearts with Takotsubo Syndrome Possible	11
Does the Number of Donor Specific Antibodies Crossed at the Time of Heart Transplant Impact Post-Transplant Outcome?	11
Is Chronic Lung Allograft Dysfunction More Common After Lung Transplantation for Pulmonary Complications of Hematopoietic Stem Cell Transplantation?	11
Malakoplakia Mimicking Endobronchial Tumor After Lung Transplantation	11
The Impact of Preformed Donor-Specific Antibodies on Outcome After Lung Transplantation: A Retrospective Single-Center Experience	11
Characteristics and Outcomes of Patients Receiving Advanced Heart Failure Therapies from a Safety-Net Hospital in the United States	11
Belatacept-Based Immunosuppression Regimen Can Stabilize Allograft Function in Patients with Antibody-Mediated Rejection	11
Bronchoalveolar Lavage Fluid Eosinophilia Associated with Worse Outcomes After Lung Transplant	11
Verticalization Therapy: Safety and Efficacy in the Cardiac Surgery ICU	11
Massive Left Ventricular Pseudoaneurysm Presenting as Cardiogenic Shock Following Myocardial Infarction	11
Renal Recovery in LVAD Recipients Requiring Renal Replacement Therapy: Preoperative Renal Failure is Better	11
Diaphragmatic Palsy -A Common Complication After LVAD Implantation	11
Impact of Reactivity Against Lymphocyte Panel and Virtual Crossmatch on Post-Cardiac Transplant Survival and Hospitalization Time	11
Determinants of Poor Survival After Heart Transplant in Patients with Renal Dysfunction. A Clinical Study with Physiological Insights from a Mathematical Model	11
Ten-Year Experience with Peritransplant Desensitization in Patients with Preformed Donor Specific Antibodies in Lung Transplantation	11
Infective Endocarditis at the Inflow Cannula of Left Ventricular Assist Device After Barefoot Walking	11
Surgical Strategy on Lung Transplantation for Kartagener’s Syndrome	10
Quantifying Total Cell-Free DNA an a Heart Transplant Patient with Acute Cellular Rejection	10
Cardiogenic Shock Due to Culture Negative Mitral Valve Endocarditis	10
ILD Strikes Back: Recurrence of Scleroderma-Related ILD After Lung Transplant	10
Two Successful Unplanned Pregnancies in a 33-Year-Old Woman After Heart Transplantation for Peripartum Cardiomyopathy	10
How is Recipient Survival Following Heart Transplantation Impacted by Donor Cancer History?	10
HLA Mismatches Identified by a Novel Algorithm Predict Risk of Antibody-Mediated Rejection from DnDSA	10
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	10
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	10
Two Phenotypes of Severe Early Graft Dysfunction Post-Heart Transplantation Based on Clinical Course - Part 1	10
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	10
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	10
Initial Experience of Sodium-Glucose Cotransporter 2 Inhibitors in Adolescents with Heart Failure Due to Muscular Dystrophy	10
Mycobacterial Infections Post Lung Transplantation - An Indian Experience	10
Coronary Artery Bypass Grafting After Orthotopic Heart Transplantation	10
Impact of Initial Hematocrit Levels During Direct Procurement and Perfusion on the Likelihood of Primary Graft Dysfunction in Donation After Circulatory Death Heart Transplant Patients	10
High-Grade Eosinophils on Diagnostic Transbronchial Biopsy are Associated with Chronic Lung Allograft Dysfunction After Lung Transplantation	10
Left Bundle Brunch Pacing in an Orthotopic Heart Transplant Patient with Heart Failure and Reduced Ejection Fraction	10
The Effects of Different Perfusion Parameters on Cardiac Graft Behavior During Langendorff	10
Torque Teno Virus Level as Predictor of Acute Rejection in Lung Transplant Recipients	9
Association of Center Volume with Post-Transplant Survival After the 2018 US Heart Allocation Policy Change	9
Information for Readers	9
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	9
Association between digoxin use and gastrointestinal bleeding in contemporary continuous flow left ventricular assist device support	9
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	9
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	9
Recipient outcomes with extended criteria donors using advanced heart preservation: Response letter and insights into the data	9
Triaging donor lungs based on a microaspiration signature that predicts adverse recipient outcome	9
Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome	9
The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience	9
Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection	9
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	9
Table of Contents	9
Aortic Root Thrombosis in patients with HeartMate 3 left ventricular assist device support	9
Anthropometrics are important to consider in purported sex differences in CTEPH outcomes	9
Covid-19 in recipients of heart and lung transplantation: Learning from experience	9
Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease	9